Diamel Therapy in Polycystic Ovary Syndrome Reduces Hyperinsulinaemia, Insulin Resistance, and Hyperandrogenaemia

Table 8

Evolution of the hormone levels in patients with PCOS during the follow up period.

Follow up	Groups
	Diamel	Placebo
Start
FSH (UI/L)	6.7±2.6	6.1±1.5
LH (UI/L)	11±6.1 *	9.7±5.3
Testosterone (nmol/L)	2.9±1.5	2.6±1.6
3 months
FSH (UI/L)	6.8±2.3	5.8±1.9
LH (UI/L)	9.9±5.9	9.2±5.4
Testosterone (nmol/L)	2.6±1.3 *	3.7±3.2 *
6 months
FSH (UI/L)	5.8±1.8	5.7±1.9
LH (UI/L)	7.6±4.9 *	8.8±4.2
Testosterone (nmol/L)	2.3±1.6	2.4±1.8

* 𝑃=0.05.
Values are means ± SD.